Home
About Us
Our Stories
Our History
Awards & Honors
Our Culture
R&D
Technology Platform
Pipeline
Manufactural Operation
Partnership
Medical
Product Information
Clinical Studies
Data Release
Join Us
Happy Life in DAC
Campus Recruitment
Social Recruitment
Contact Us
Contact Information
Message Board
EN
中文
EN
Search
About Us
Our Stories
Our History
Awards & Honors
Our Culture
R&D
Technology Platform
Pipeline
Manufactural Operation
Partnership
Medical
Product Information
Clinical Studies
Data Release
Join Us
Happy Life in DAC
Campus Recruitment
Social Recruitment
Contact Us
Contact Information
Message Board
EN
中文
EN
Home
About Us
Our Stories
Our History
Awards & Honors
Our Culture
R&D
Technology Platform
Pipeline
Manufactural Operation
Partnership
Medical
Product Information
Clinical Studies
Data Release
Join Us
Happy Life in DAC
Campus Recruitment
Social Recruitment
Contact Us
Contact Information
Message Board
Medical Information
Product Information
Clinical Studies
Data Release
Clinical Studies
Product Information
Clinical Studies
Data Release
Clinical Studies
Patients recruited
DX126-262 is a Phase I clinical trial of Duoxi Biotech for the treatment of advanced HER2-positive solid tumors
More
HANGZHOU DAC BIOTECHNOLOGY CO .,LTD
Address
369 Qiaoxin Road, Qiantang District, Hangzhou 310018 Zhejiang, China
Telephone
0571-56050590
Email
duoxi@dacbiotech.com
Official accounts
Links
Links
Center For DRUG EVALUTION NMPA
